The End is Near...

Quote












Isn't it time to be honest and give up the charade? Why aren't the analysts questioning the lack of transparency with Oralair numbers and abysmal number of scripts? How do Rick and Chris still have their jobs? Only person more useless is Tiffany.
 


















anonymous said:
Isn't it time to be honest and give up the charade? Why aren't the analysts questioning the lack of transparency with Oralair numbers and abysmal number of scripts? How do Rick and Chris still have their jobs? Only person more useless is Tiffany.
Click to expand...

As a former employee who was around when OralAir came out. They told us we had to have 140 scripts per quarter. Two per doctor. Anyone with even a small amount of knowledge on allergy immunotherapy knew that wasn't going to ever happen. There is a reason there are no more tenured reps at Greer. They saw the writing on the wall. It seems finally the new reps are seeing how pathetic of a product OralAir is. I would love to hear where the script numbers are now.
 






anonymous said:
As a former employee who was around when OralAir came out. They told us we had to have 140 scripts per quarter. Two per doctor. Anyone with even a small amount of knowledge on allergy immunotherapy knew that wasn't going to ever happen. There is a reason there are no more tenured reps at Greer. They saw the writing on the wall. It seems finally the new reps are seeing how pathetic of a product OralAir is. I would love to hear where the script numbers are now.
Click to expand...
Only a handful of reps in double digits for scripts.
 












The top rep has 50 and there are 3 in the low 30's or 30 2 in the low 20's and the rest are teens and single digits. These are for the quarter in peek season around the country. You would have to add the entire company to get the expectations they had for one territory. So many are looking or being forced out.
 


















I heard senior managers were told that the Primary Care phase of selling would be the last rodeo for ORALAIR in the U.S. - at least with the investments being made currently. Probably April 2017 is as long as corp will give to this product.
 












anonymous said:
I heard senior managers were told that the Primary Care phase of selling would be the last rodeo for ORALAIR in the U.S. - at least with the investments being made currently. Probably April 2017 is as long as corp will give to this product.
Click to expand...
Will not make a difference. They should have done what Merck did.
 






























And the target PCPs are already doing shot therapy? Seriously, how is senior management not thrown out on their ass? Or are they just hoping to preserve their job for a few more months and get severance? Good lesson in how to destroy a previously great company.
 












Top Bottom
Back
Quote